Bioaffinity Technologies Warrant Stock Last Dividend Paid

BIAFW Stock

USD 0.72 0.03 4.00%

bioAffinity Technologies Warrant fundamentals help investors to digest information that contributes to BioAffinity Technologies' financial success or failures. It also enables traders to predict the movement of BioAffinity Stock. The fundamental analysis module provides a way to measure BioAffinity Technologies' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to BioAffinity Technologies stock.

Short Long Term Debt Total Total Assets

This module does not cover all equities due to inconsistencies in global equity categorizations. Continue to Equity Screeners to view more equity screening tools.

bioAffinity Technologies Warrant Company Last Dividend Paid Analysis

BioAffinity Technologies' Last Dividend Paid refers to dividend per share(DPS) paid to the shareholder the last time dividends were issued by a company. In its conventional sense, dividends refer to the distribution of some of a company's net earnings or capital gains decided by the board of directors.

Last Dividend

Last Profit Distribution Amount

Total Shares

More About Last Dividend Paid | All Equity Analysis

BioAffinity Last Dividend Paid Driver Correlations

Understanding the fundamental principles of building solid financial models for BioAffinity Technologies is extremely important. It helps to project a fair market value of BioAffinity Stock properly, considering its historical fundamentals such as Last Dividend Paid. Since BioAffinity Technologies' main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of BioAffinity Technologies' historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of BioAffinity Technologies' interrelated accounts and indicators.

	Total Assets	Total Stockholder Equity	Net Debt	Retained Earnings	Accounts Payable	Net Receivables	Total Liab	Total Current Assets	Short Term Debt	Common Stock	Long Term Debt	Net Invested Capital	Short Long Term Debt	Capital Stock	Net Working Capital	Current Deferred Revenue	Intangible Assets
Total Assets		0.78	-0.85	-0.8	0.81	0.51	-0.33	0.95	-0.57	0.95	0.81	0.98	-0.91	0.95	0.98	-0.42	-0.42
Total Stockholder Equity	0.78		-0.96	-0.52	0.5	0.5	-0.8	0.74	-0.95	0.76	0.4	0.8	-0.82	0.77	0.82	-0.47	-0.47
Net Debt	-0.85	-0.96		0.49	-0.47	-0.33	0.73	-0.87	0.86	-0.76	-0.44	-0.85	0.79	-0.76	-0.87	0.31	0.31
Retained Earnings	-0.8	-0.52	0.49		-0.91	-0.84	-0.08	-0.67	0.32	-0.85	-0.87	-0.86	0.9	-0.88	-0.83	0.8	0.8
Accounts Payable	0.81	0.5	-0.47	-0.91		0.79	-0.02	0.62	-0.33	0.93	0.89	0.8	-0.85	0.93	0.78	-0.63	-0.63
Net Receivables	0.51	0.5	-0.33	-0.84	0.79		-0.1	0.29	-0.46	0.69	0.59	0.6	-0.79	0.73	0.58	-0.95	-0.95
Total Liab	-0.33	-0.8	0.73	-0.08	-0.02	-0.1		-0.32	0.91	-0.32	0.12	-0.3	0.33	-0.31	-0.34	0.04	0.04
Total Current Assets	0.95	0.74	-0.87	-0.67	0.62	0.29	-0.32		-0.52	0.82	0.7	0.94	-0.81	0.82	0.94	-0.27	-0.27
Short Term Debt	-0.57	-0.95	0.86	0.32	-0.33	-0.46	0.91	-0.52		-0.6	-0.16	-0.6	0.67	-0.61	-0.63	0.44	0.44
Common Stock	0.95	0.76	-0.76	-0.85	0.93	0.69	-0.32	0.82	-0.6		0.83	0.93	-0.94	1.0	0.93	-0.55	-0.55
Long Term Debt	0.81	0.4	-0.44	-0.87	0.89	0.59	0.12	0.7	-0.16	0.83		0.78	-0.74	0.82	0.75	-0.47	-0.47
Net Invested Capital	0.98	0.8	-0.85	-0.86	0.8	0.6	-0.3	0.94	-0.6	0.93	0.78		-0.96	0.94	1.0	-0.56	-0.56
Short Long Term Debt	-0.91	-0.82	0.79	0.9	-0.85	-0.79	0.33	-0.81	0.67	-0.94	-0.74	-0.96		-0.96	-0.96	0.74	0.74
Capital Stock	0.95	0.77	-0.76	-0.88	0.93	0.73	-0.31	0.82	-0.61	1.0	0.82	0.94	-0.96		0.94	-0.6	-0.6
Net Working Capital	0.98	0.82	-0.87	-0.83	0.78	0.58	-0.34	0.94	-0.63	0.93	0.75	1.0	-0.96	0.94		-0.54	-0.54
Current Deferred Revenue	-0.42	-0.47	0.31	0.8	-0.63	-0.95	0.04	-0.27	0.44	-0.55	-0.47	-0.56	0.74	-0.6	-0.54		1.0
Intangible Assets	-0.42	-0.47	0.31	0.8	-0.63	-0.95	0.04	-0.27	0.44	-0.55	-0.47	-0.56	0.74	-0.6	-0.54	1.0

Click cells to compare fundamentals

Many stable companies today pay out dividends to their shareholders in the form of the income distribution, but high-growth firms rarely offer dividends because all of their earnings are reinvested back to the business.

Competition

Predict BioAffinity Technologies

Based on the recorded statements, bioAffinity Technologies Warrant has a Last Dividend Paid of 0.0. This indicator is about the same for the Biotechnology average (which is currently at 0.0) sector and about the same as Health Care (which currently averages 0.0) industry. This indicator is about the same for all United States stocks average (which is currently at 0.0).

Did you try this?

Run Economic Indicators Now

Economic Indicators

Top statistical indicators that provide insights into how an economy is performing

All Next

Launch Module

BioAffinity Fundamentals

	Return On Equity	-1.52
	Return On Asset	-0.7
	Profit Margin	(1.19) %
	Operating Margin	(0.87) %
	Revenue	2.53 M
	EBITDA	(7.63 M)
	Net Income	(7.94 M)
	Cash And Equivalents	214.4 K
	Cash Per Share	0.08 X
	Total Debt	1.58 M
	Current Ratio	0.02 X
	Book Value Per Share	0.52 X
	Cash Flow From Operations	(6.04 M)
	Number Of Employees	75
	Beta	3.12
	Total Asset	8.22 M
	Retained Earnings	(44.6 M)
	Working Capital	1.72 M
	Net Asset	8.22 M

About BioAffinity Technologies Fundamental Analysis

The Macroaxis Fundamental Analysis modules help investors analyze bioAffinity Technologies Warrant's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of BioAffinity Technologies using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of bioAffinity Technologies Warrant based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.

Please read more on our fundamental analysis page.

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

V	Visa Class A
GOOG	Alphabet Inc Class C
GOOG	Alphabet Inc Class C

Additional Tools for BioAffinity Stock Analysis

When running BioAffinity Technologies' price analysis, check to measure BioAffinity Technologies' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy BioAffinity Technologies is operating at the current time. Most of BioAffinity Technologies' value examination focuses on studying past and present price action to predict the probability of BioAffinity Technologies' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move BioAffinity Technologies' price. Additionally, you may evaluate how the addition of BioAffinity Technologies to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC